TotalMarketCap

Madrigal Pharmaceuticals

MDGLNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$9.299 B

$400.30 -0.03%

Close of 6 Nov 2026

As of 6 Nov 2026, Madrigal Pharmaceuticals (MDGL) has a market capitalization of $9.30B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$180.1M

#2304 by revenue

Earnings

-$288.3M

Loss-making

Shares outstanding

23,229,561

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #31Summit TherapeuticsSMMT$11.5B
  2. #32Biomarin PharmaceuticalBMRN$10.9B
  3. #33Madrigal PharmaceuticalsMDGL$9.30B
  4. #34Spyre TherapeuticsSYRE$9.21B
  5. #35Tg TherapeuticsTGTX$8.87B

What if Madrigal Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,215,558

Per share 3,037× higher

Bitcoin $1.53T

$65,771.72

Per share 164× higher

Apple $5.02T

$215,922.40

Per share 539× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Madrigal Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.